Production processClosed Production

Products 91 to 100 of 174

Biotech components: Enzyme
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: 200,000,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: HALO (NASDAQ)
Value chain stage: Finished Product
Insulin-producing bacteria by Venter Institute
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/10/01 09:50 (2 years ago)
Known funding amount: 50,000 USD
Funding types: Foundation
Industry: Health
Market status: Early Stage Concept
Organization type(s): Research Institution
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Isobutanol by Gevo
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: 92,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: GEVO (NASDAQ)
Value chain stage: Input
Isobutene by Global Bioenergies
Biotech components: Plant
Business models: B2B
Country of production: France
Country of distribution: France + Netherlands + Germany
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: 23,000,000 EUR
Funding types: Shareholder Investment
Industry: Industrial
Market status: Under Development
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: ALGBE (EPA)
Value chain stage: Input
L-Methionine by Metabolic Explorer SA
Biotech components: Enzyme
Business models: B2B
Country of production: France
Country of distribution: France
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Public Company
Product categories: Feed
Production process: Closed Production
Source: SynBio Database
Trading symbol: METEX (EPA)
Value chain stage: Input
PCR-produced linear DNA by Applied DNA Sciences + LineaRx
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2019/01/30 11:54 (2 years ago)
Known funding amount: 19,800,000 USD
Funding types: Shareholder Investment
Industry: Science
Market status: On the market
Organization type(s): Public Company
Product categories: Research
Production process: Closed Production
Source: NASEM Database
Trading symbol: APDN (NASDAQ)
Value chain stage: Platform
Biotech components: Enzyme
Business models: B2B
Country of production: Denmark
Country of distribution: Denmark + China
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/10/08 14:50 (2 years ago)
Known funding amount: 12,880,000 DKK
Funding types: Shareholder Investment
Industry: Industrial
Market status: Under Development
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: Web search
Trading symbol: NZYM-B (CPH)
Value chain stage: Input
Luminase PB-100 by BASF
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: Germany + USA + Brazil + China
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: 85,090,000 EUR
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BASF SE (ETR)
Value chain stage: Input
Lux Algal Oil Soap by Lux (Unilever)
Biotech components: Plant
Business models: B2C
Country of production: UK
Country of distribution: Brazil + UK
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: ULVR (LSE)
Value chain stage: Finished Product
Malonic Acid by Lygos, Inc (Advanced Biofuels Process Demonstration Unit)
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: 13,100,000 USD
Funding types: Venture Capital
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input